List of Advil Allergy Sinus drug patents

Advil Allergy Sinus is owned by Glaxosmithkline.

Advil Allergy Sinus contains Chlorpheniramine Maleate; Ibuprofen; Pseudoephedrine Hydrochloride.

Advil Allergy Sinus has a total of 1 drug patent out of which 0 drug patents have expired.

Advil Allergy Sinus was authorised for market use on 19 December, 2002.

Advil Allergy Sinus is available in tablet;oral dosage forms.

The generics of Advil Allergy Sinus are possible to be released after 28 February, 2027.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7863287 GLAXOSMITHKLINE Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
Feb, 2027

(4 years from now)

Drugs and Companies using CHLORPHENIRAMINE MALEATE; IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE ingredient

Market Authorisation Date: 19 December, 2002

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic